News Center

Home page

Peak Report

News reports

Jianfeng Group Pro 2015-007 (Jianfeng Group Daily Related Party Transaction Announcement)

Release time:

2020-08-05

Securities Abbreviations: Jianfeng Group Securities Code: 600668 No.: Pro 2015-007

Bond Abbreviations: 13 Peak 01 Bond Code: 122227

Bond Abbreviations: 13 Peak 02 Bond Code: 122344

Zhejiang Jianfeng Group Co., Ltd.

Regular Related Party Transaction Announcement

The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and shall bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents .

Basic Information of 1. Daily Related Party Transactions

Review Procedures for Implementation of (I) Daily Related Party Transactions

Jinhua Pharmaceutical Co., Ltd. (hereinafter referred to as "Jinhua Pharmaceutical Company") purchases drugs from related party Tianjin Tianshili Pharmaceutical Marketing Group Co., Ltd. (hereinafter referred to as "Tianshili Marketing Group"). It is estimated that the purchase amount in 2015 will be between 0.5 and 5% of the company's audited net assets at the end of 2014 (no more than 103.0351 million yuan). Therefore, this related party transaction needs to be submitted to the board of directors for deliberation, but does not need to be submitted to the general meeting of shareholders for deliberation.

On April 17, 2015, the company held the second meeting of the ninth board of directors. All nine directors of the company attended the meeting in person. The related directors Mr. Jiang Xiaomeng and Mr. Du Zihong avoided voting on the proposal, which complied with the relevant provisions of the "Company Law" and the "Articles of Association", and the resolutions made were legal and effective. After deliberation and voting, the board of directors deliberated and passed the daily related party transaction proposal with 7 votes in favor, 0 votes against and 0 abstention.

The independent directors of the company reviewed the matter in advance and agreed to submit the proposal to the second meeting of the ninth board of directors of the company for deliberation. The independent directors of the company expressed their independent opinions on the adoption of the proposal by the board of directors, and believed that the formation of the resolution complied with the "Company Law", the company's "Articles of Association" and other relevant provisions, and did not harm the interests of small and medium shareholders.

Forecast and Implementation of (II)'s Last Daily Related Party Transaction

The Company issued a public announcement on April 15, 2014. It is estimated that the amount of drugs purchased by Jinhua Pharmaceutical Company from Tianshili Marketing Group in 2014 will be between 0.5 and 5% (between 8.685 million yuan and 86.8499 million yuan) of the Company's audited net assets at the end of 2013. The actual amount incurred in 2014 was 14.6314 million yuan, accounting for 2.13 percent of the amount of similar transactions, which did not exceed the expected range.

2. Related Party Introduction and Association Relationship

(I) the basic situation of related parties.

1. Jinhua Pharmaceutical Company: Established in January 1994, its domicile is located at 1180 Huancheng East Road, Jinhua City, its legal representative is Jin Xuecai, and its registered capital is 22 million yuan, of which: the company accounts for 10%, Zhejiang Jianfeng Pharmaceutical Co., Ltd., its holding subsidiary, accounts for 90%, and its main business is drug management. Wholesale and retail of prepackaged food; dangerous chemicals and medical devices; chemical reagents (except dangerous goods); glass and products; textiles, clothing and household daily necessities (except dangerous goods); fitness equipment supplies; computers, software and auxiliary equipment; wholesale and retail of teaching molds; exhibition services; medical information services; branches operate with valid certificates: purchase and processing of traditional Chinese medicine. The drug business license mainly includes: sales of proprietary Chinese medicines, Chinese medicinal materials, Chinese medicinal tablets, chemical preparations, chemical raw materials, antibiotics, biochemical drugs, biological products, narcotic drugs, psychotropic drugs, etc. The audited net profit for 2014 was 6.5056 million yuan, the net assets at the end of 2014 was 73.169 million yuan, and the liabilities were 237.9614 million yuan.

2, Tianshili Marketing Group: The company was established in 1999 February. The company's domicile is Tianshili Modern Chinese Medicine City, Xinyibai Avenue, Beichen Science and Technology Park, Tianjin, with its legal representative Yan Kaijing and registered capital of 25900 yuan, the business scope is the wholesale of Chinese herbal pieces, Chinese medicinal materials, Chinese patent medicines, chemical raw materials and their preparations, antibiotics, biochemical drugs, biological products, and diagnostic drugs; chemical raw materials ( except hazardous chemicals and precursor drugs ) , Wholesale and retail of cosmetics, daily chemical products, packaging materials and containers, plastic products, molds, and plastic raw materials; health food (hard capsules, soft capsules, granules, tablets, oral liquids, tea bags, health wine) wholesale and retail; disposable sterile syringes (needles), infusion sets (needles), corneal contact lenses and nursing solutions, medical polymer materials and products, physical therapy and rehabilitation equipment, medical hygiene materials and dressings, Chinese medicine equipment, general diagnosis equipment, Ward care equipment and appliances, household blood glucose meters and test strips, pregnancy diagnosis test strips, condoms wholesale; self-employed and agent of all kinds of goods and technology import and export business, but the state restricts the company to operate or prohibits the import and export of goods and technology, operating feed processing and "three to one supplement " business, operating trade and re-export trade, pre-packaged food wholesale and retail. The net profit attributable to the parent company in 2014 was 16,080.14 yuan, The net assets attributable to the parent company at the end of 2014 were 9,234.05 yuan, and the liabilities were 482,239.84 yuan.

The relationship between the (II) and the listed company

Because Tianshili Marketing Group is the holding subsidiary of Tianshili Pharmaceutical Group Co., Ltd., and Tianshili Pharmaceutical Group Co., Ltd. is the holding subsidiary of Tianshili Holding Group Co., Ltd. (hereinafter referred to as "Tianshili Group"), tasly Group is an associate of the Company and the Company has two directors who are also directors of Tasly Group, so Jinhua Pharmaceutical Company is related to Tasly Marketing Group.

(III) The amount of related party transactions in 2014 was 14.6314 million yuan, accounting for 2.13 percent of the amount of similar transactions. The implementation was good and there were no disputes.

Main Contents and Pricing Policy of 3. Related Party Transaction

Jinhua Pharmaceutical Company plans to continue to purchase drugs from Tianshili Marketing Group for sale this year. The main contents of this related party transaction are as follows:

(1) Transaction Target: Compound Danshen Dripping Pills, Yangxue Qingnao Granules, etc.

(2) Transaction Price: Agreement Price.

(3) settlement method: full payment according to the sales amount of last month.

(4) Agreement Validity Period: The validity period of the agreement signed by the above-mentioned related parties is 1 year from the date of signature by the legal representatives or authorized representatives of both parties.

(5) Other matters: If there is a major change in the content of this related party transaction during the implementation of the agreement, the company will disclose it in accordance with relevant regulations, and investors are requested to pay attention.

Purpose of 4. Related Party Transaction and Impact on Listed Companies

This related party transaction is to use Jinhua Pharmaceutical Company's existing sales network in Zhejiang Province to purchase drugs from Tianshili Marketing Group for distribution and sales, thus expanding Jinhua Pharmaceutical Company's business scope, further enhancing the Company's market influence and enhancing the Company's marketing capability. At the same time, Tasly Marketing Group is an indirect holding subsidiary of the Company's associates, and the expansion of its sales channels has increased the scale of corporate sales. The connected transaction will not harm the interests of the Company or the minority shareholders.

hereby announce

Zhejiang Jianfeng Group Co., Ltd.

Board of Directors

April 21, 2015

More information

Company Leaders Attend Jinhua Development Conference

News from our newspaper On November 17, the second 2019 Jinhua Development Conference with the theme of "Insist on high-quality integration into the Yangtze River Delta to build a metropolitan area" opened in Jinhua, Zhejiang. More than a thousand people from the scientific and educational circles, business circles, and overseas Chinese from home and abroad Business people, representatives of "New Golden Chinese" and representatives of outstanding Jinhua students attended the meeting. Group leaders Jiang Xiaomeng, Yu Jianhong and Huang Jinlong attended the relevant activities of the conference. As a representative of the Jinhua business community, Jiang Xiaomeng, chairman of the group company, made a keynote speech at the "Scientist" and "Entrepreneur" Innovation Dialogue of the Development Conference, expressing his views on how Jinhua enterprises can improve their technological competitiveness. As the head of Jinhua local enterprise with a history of more than 60 years, Jiang Xiaomeng has a profound experience in promoting the development of enterprises through science and technology. Combined with the reality of peak scientific and technological innovation, he pointed out in his speech that the improvement of scientific and technological innovation ability is an urgent event for Jinhua small and medium-sized enterprises. Private enterprises cannot achieve high-quality development without the support of scientific and technological forces; with the progress of society, the improvement of people's living standards and the continuous improvement of cultural quality, the demand for products and the pursuit of product quality have also undergone qualitative changes. Only products with scientific and technological connotations can attract consumers. He suggested that the government and relevant institutions should establish an information platform to further understand the scientific and technological support that enterprises need in the transformation, understand what kind of help scientific and technological personnel can provide to enterprises, do a good job in the information docking of scientists and entrepreneurs, further attract investment and wisdom, give full play to the scientific and technological achievements of academicians and experts and the capital advantages of businessmen at home and abroad, and promote Jinhua enterprises to better integrate into Changsan

2020

07-30

Spike Nineteen Awarded "Celebrating the 70th Anniversary of the the People's Republic of China" Commemorative Medals

News from our newspaper Before the National Day, the Central Committee of the Communist Party of China, the State Council, and the Central Military Commission jointly issued the "Celebrating the 70th Anniversary of the Founding of the the People's Republic of China" commemorative medal. 19 veteran comrades including former chairman Du Zihong won this honor. It is understood that the "Celebrating the 70th Anniversary of the Founding of the the People's Republic of China" commemorative medals are awarded to eligible persons among the following objects: veterans and comrades who participated in the revolutionary work before the establishment of the the People's Republic of China; after the establishment of the the People's Republic of China, they have won national commendations and awards and above honors and are still alive. After the establishment of the the People's Republic of China, military personnel (including veterans) who have won first-class awards and are still alive; international friends who have made outstanding contributions to the establishment of the the People's Republic of China; those who died after January 1, 2019 are within the scope of this issuance. The issuance of the "Celebrating the 70th Anniversary of the Founding of the People's Republic of China China" commemorative medal is an important part of the series of celebrations for the 70th anniversary of the founding of New China. It is important for strengthening patriotism education, cultivating and practicing the core values of socialism, and enhancing the cohesion and appeal of the great cause of socialism with Chinese characteristics., Has a very important meaning. Among the 19 people who won the commemorative medals, Zheng Yunya, Xu Zeng, Wu Bingyin, Wang Zhendong, Gao Changxuan, Shi Gao, Zhou Zucheng, and Lu Weitang were retired cadres who took part in revolutionary work before the founding of New China, and Huang Jingui, Mou Dehua, and Zhang Wancai were old workers who took part in the work before the founding of New China, du Zihong, Fang Lianbai, Feng Hanwei, Tang Yanru, Wang Xinghua, Huang Shaobao, Huang Xiehe, etc. made outstanding contributions to national construction after the founding of New China and won

2020

07-31

Pinnacle International Trade Hosts Cotton Spinning Forum

In order to better play the role of cotton yarn futures delivery warehouse and promote the development of textile industry in the region, on September 24, peak international trading company and earth futures co., ltd. jointly held a "talk on cotton 2019-earth peak forum". With the theme of "Market Trends and Prospects of Cotton Textile Industry", the forum gathered more than 70 people from Hangzhou, Shaoxing, Shanghai, Lanxi, Changzhou, Jiangyin, Nantong and other parts of the country, as well as India and Vietnam, to seek common development plans for the cotton spinning industry. After obtaining the qualification of the designated cotton yarn delivery warehouse of Zhengzhou Commodity Exchange, the peak international trade actively implemented the work of the cotton yarn delivery warehouse. Hosting this forum is an important link for Jianfeng International Trade to start the cotton yarn delivery warehouse business. It aims to build an exchange platform for the cotton spinning industry, deeply study the operation rules of cotton yarn futures, enable textile mills, weaving mills and cotton yarn traders to quickly understand the Jianfeng warehouse and cotton yarn futures delivery and storage business, and jointly discuss the development trend of the cotton textile industry. Yu Jianhong, general manager of the group company, attended the meeting and delivered a speech. He expressed his gratitude and welcome to the guests who came to the forum, and said that Jinhua is located in the heart of Zhejiang, and its subordinate Lanxi City is China's main cotton textile industry base. The second pillar industry of Yiwu City is also the knitting industry. The demand for cotton yarn is huge. Peak International Trade to obtain cotton yarn futures delivery qualification, not only for Lanxi, Yiwu cotton textile industry and upstream and downstream merchants nearby to provide cotton yarn spot storage and futures delivery sites, but also can effectively serve this, service the province, and radiation to Jiangxi, Fujian and East China and other places. This forum

2020

07-31

Pinnacle International Trade Hosts Cotton Spinning Forum

2020

07-31

Pinnacle International Trade Hosts Cotton Spinning Forum

2020

07-22

Pinnacle International Trade Hosts Cotton Spinning Forum

2020

07-30

< 1...27 28 29...61 > 跳转到页